Loading insider details...
Latest Form 4 (Oct 13, 2026): Exercise/Conversion of 13,833 LQDA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Liquidia Corp (LQDA) | Exercise/Conversion | 13,833 | n/a |
| Jul 15, 2026 | Liquidia Corp (LQDA) | Exercise/Conversion | 13,834 | n/a |
| Jun 12, 2026 | Axsome Therapeutics, Inc. (AXSM) | Sale | 286 | $70.4K |
| Jun 11, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 1,429 | n/a |
| Jun 9, 2026 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 1,721 | n/a |
| May 28, 2026 | Liquidia Corp (LQDA) | Sale | 6,428 | $399.7K |
| May 26, 2026 | Liquidia Corp (LQDA) | Sale | 25,000 | $1.53M |
| May 20, 2026 | Liquidia Corp (LQDA) | Sale | 25,000 | $1.42M |
| May 15, 2026 | Liquidia Corp (LQDA) | Sale | 25,000 | $1.41M |
| May 12, 2026 | Liquidia Corp (LQDA) | Sale | 25,000 | $1.05M |